InvestorsHub Logo
icon url

Love Boat Captain

07/01/24 9:13 PM

#703167 RE: beartrap12 #703147

Thank you for the kind words beartrap12! I agree with your points about NICE's involvement. The data collection and the proactive approach from NICE show their commitment to helping NWBO navigate the pricing process for DCVax-L. Given the significant interest from the brain cancer community and the potential benefits for patients, it's clear that Great Britain is eager to see this treatment approved. At this point, the only fitting response to any skepticism is "let's see," as all signs indicate a strong push towards making DCVax-L commercially available.